There are 412 resources available
Mitigating adverse events, improving adherence/persistence, and maximizing treatment benefits from CDK4/6 inhibitors in high-risk, HR+, HER2- EBC
Presenter: Patrick Neven
Session: PeerView Oncology - supported by Lilly - Safeguarding patients with HR+, HER2-, high-risk, early breast cancer: A practical roadmap for CDK4/6 inhibition in the adjuvant setting
Resources:
Webcast
Q&A, synthesis, and conclusions
Session: PeerView Oncology - supported by Lilly - Safeguarding patients with HR+, HER2-, high-risk, early breast cancer: A practical roadmap for CDK4/6 inhibition in the adjuvant setting
Resources:
Webcast
Introduction to, and presentation of, the award
Presenter: Fabrice André
Session: ESMO Breast Cancer 2024 award lecture
Resources:
Slides
Webcast
How future therapeutic research is shaped through lessons learned from treatment development for metastatic breast cancer
Presenter: Hope Rugo
Session: ESMO Breast Cancer 2024 award lecture
Resources:
Slides
Webcast
A living biobank to study breast cancer progression
Presenter: Colinda Scheele
Session: Lessons from recent translational approaches
Resources:
Slides
Webcast
Case presentation
Presenter: Peter Dubsky
Session: Axillary management in the post-neoadjuvant setting: Local therapy, prognostic information and quality of life (QoL)
Resources:
Slides
Webcast
Adjuvant CDK inhibitors: The new treatment paradigm for high risk HR+HER2- breast cancer
Presenter: Joseph Gligorov
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast
The surgeon: When and how can surgeons optimize lymph node resection
Presenter: Andre Pfob
Session: Axillary management in the post-neoadjuvant setting: Local therapy, prognostic information and quality of life (QoL)
Resources:
Slides
Webcast
Can novel endocrine agents optimise adjuvant therapy further?
Presenter: Patrick Neven
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast
Extended adjuvant chemotherapy for luminal cancers
Presenter: Masakazu Toi
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast